Back to Journals » Clinical Ophthalmology » Volume 10

Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion

Authors Hall J, C Wright C

Received 5 July 2016

Accepted for publication 13 July 2016

Published 25 August 2016 Volume 2016:10 Pages 1631—1632

DOI https://doi.org/10.2147/OPTH.S116539

Checked for plagiarism Yes


John Hall

Alimera Sciences Ltd., Aldershot, Hampshire, UK

I read “Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion” published in May 2016 by Sobha Sivaprasad and Sesan Oyetunde. The article is extremely important as it explains why short- and long-acting corticosteroids are so important in reducing intravitreal injections in clinic practices and the number of visits to the clinic. The authors present a valid point that this can be achieved with no impact on visual outcomes in diabetic macular edema (DME) and retinal vein occlusion. However, having read the article in detail, I would like to raise two important oversights that the authors have failed to address and are potentially misleading, and these are highlighted in the following section.

View the original paper by Sivaprasad and Oytunde.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]